Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Active Surveillance for Low-Risk Prostate Cancer—An Evolving International Standard of Care

Active Surveillance for Low-Risk Prostate Cancer—An Evolving International Standard of Care Research Brief Report Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden ARTICLE INFORMATION Disclaimer: The content is solely the responsibility 5. Loeb S, Berglund A, Stattin P. Population based of the authors and does not represent the official study of use and determinants of active surveillance Accepted for Publication: June 23, 2016. views of the NIH. and watchful waiting for low and intermediate risk Published Online: October 20, 2016. prostate cancer. J Urol. 2013;190(5):1742-1749. Previous Presentation: An abstract based on these doi:10.1001/jamaoncol.2016.3600 data were presented at the American Urological 6. Tomic K, Berglund A, Robinson D, et al. Capture Author Contributions: Mr Folkvaljon had full Association meeting; May 6, 2016; San Diego, CA. rate and representativity of The National Prostate access to all the data in the study and takes Cancer Register of Sweden. Acta Oncol. 2015;54(2): Additional Contributions: This project was made responsibility for the integrity of the data and the 158-163. possible by the continuous work of the National accuracy of the data analysis. Prostate Cancer Register of Sweden (NPCR) steering 7. Van Hemelrijck M, Wigertz A, Sandin F, et al; Study concept and design: Loeb, Folkvaljon, Bratt, committee: Pär Stattin, MD, PhD, chairman; Anders NPCR and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Active Surveillance for Low-Risk Prostate Cancer—An Evolving International Standard of Care

JAMA Oncology , Volume 3 (10) – Oct 20, 2017

Loading next page...
 
/lp/american-medical-association/active-surveillance-for-low-risk-prostate-cancer-an-evolving-7TLDvCBmP4

References (8)

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2016.3179
Publisher site
See Article on Publisher Site

Abstract

Research Brief Report Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden ARTICLE INFORMATION Disclaimer: The content is solely the responsibility 5. Loeb S, Berglund A, Stattin P. Population based of the authors and does not represent the official study of use and determinants of active surveillance Accepted for Publication: June 23, 2016. views of the NIH. and watchful waiting for low and intermediate risk Published Online: October 20, 2016. prostate cancer. J Urol. 2013;190(5):1742-1749. Previous Presentation: An abstract based on these doi:10.1001/jamaoncol.2016.3600 data were presented at the American Urological 6. Tomic K, Berglund A, Robinson D, et al. Capture Author Contributions: Mr Folkvaljon had full Association meeting; May 6, 2016; San Diego, CA. rate and representativity of The National Prostate access to all the data in the study and takes Cancer Register of Sweden. Acta Oncol. 2015;54(2): Additional Contributions: This project was made responsibility for the integrity of the data and the 158-163. possible by the continuous work of the National accuracy of the data analysis. Prostate Cancer Register of Sweden (NPCR) steering 7. Van Hemelrijck M, Wigertz A, Sandin F, et al; Study concept and design: Loeb, Folkvaljon, Bratt, committee: Pär Stattin, MD, PhD, chairman; Anders NPCR and

Journal

JAMA OncologyAmerican Medical Association

Published: Oct 20, 2017

There are no references for this article.